12202596.txt 0 labor   cost requirements   two commercial assays   qualitative molecular detection   hepatitis c virus
12202596.txt 1   bayer transcriptionmediated amplification tma     roche pcr amplicor version 20 molecular assays     qualitative detection   hepatitis c virus were compared   cost hands  time assay duration   complexity   tma assay compares well   pcr   may   especially useful   laboratories   large numbers   test requests
12202596.txt 2 
12202596.txt 3 since   cloning     hepatitis c virus hcv genome   1989  diagnosis   infection has been performed   various immunologic   molecular genetic assays    addition     traditional examination   liver biopsy specimens direct amplification   hcv rna provides early evidence   infection independent     patients immunological status     an important tool     assessment   viral clearance   thus response   therapy    performed   time motion study   compared cost   reagents   disposables labor involved   testing   instrument maintenance time   result   hands time     bayer transcriptionmediated amplification tma assay versus   roche pcr amplicor version 20   current standard protocol   roche pcr assay roche molecular systems inc pleasanton calif utilizes reverse transcriptionpcr    brief samples   prepared   precipitation     viral rna   addition   an hcv internal control rna   assay quality control subsequently   target rna   reverse transcribed     amplified   specific hcv primers     designed     highly conserved 5 untranslated region     viral genome targetspecific oligonucleotide probes hybridize     amplified products   presence     hybridization product   established   colorimetric analysis     cobas amplicor analyzer   qualitative bayer assay  amplifies rna     vitro transcription     dna template   viral nucleic acids     specimen   well   those   an internal control   hybridized   capture oligonucleotides complementary   highly conserved hcv 5untranslatedregion sequences   rna   subsequently captured   magnetic microbeads after   addition   primers reverse transcriptase   t7 rna polymerase rna   amplified     dna template during   1h incubation   415c singlestranded fluorescently labeled probes     hybridized     rna amplicons whereas unhybridized probes   chemically degraded   leader hc luminometer genprobe san diego calif distinguishes   chemiluminescent signals     target sequence     samples     internal control   differential light emission bayer diagnostics division norwood mass   evaluated 182 patient sera     tma assay   182 samples included specimens sent     laboratory   hcv enzyme immunoassay hcv recombinant immunoblot assay riba   qualitative   quantitative hcv pcr     roche assay   also included random specimens   were assessed   analytes   related   hcv such   human immunodeficiency virus hepatitis     b viruses cytomegalovirus syphilis organisms   rubella   varicella zoster virus   side side evaluation     tma assay     pcr assays was performed   172   182 samples   tma assay runs   24 54   94 patient samples   comparison   either 10 one ring   22 two rings patient sample runs     roche system   included one positive   one negative control sample   each roche ring   three positive   well   three negative calibrators   each tma assay run twelve     172 samples were duplicates   reasons   related     assay   remaining 10   182 samples were   directly compared     roche method   were used   evaluate   possibility   performing innolipa genotyping innogenetics inc norcross ga after   tma assay   study population consisted   10 samples   indeterminate riba results   65   hcv antibodypositive results     170 samples 25 were originally sent   testing   roche pcr   an additional 10 were both positive   pcr   subsequently genotyped     innolipa system innogenetics inc  sixty were random samples tested   hcv   priori     tma assay   pcr comparison   total   65   170 samples were hcv positive   either qualitative   quantitative pcr roche amplicor   66   170 were positive     tma assay   sample newly identified   positive   tma analysis remained negative   qualitative pcr   repeat testing   finding may reflect either   falsepositive result higher sensitivity     tma assay   pcr inhibition     sample   sample was subsequently determined     negative   riba chiron corporation emeryville calif         less sensitive assay than pcr     tma assay therefore   true status     specimen could     determined results were obtained     tma samples whereas two pcr samples failed   undergo amplification after several attempts results     12 samples   were duplicated     tma assay were entirely equivalent   tma assay requires   sample volume   500 mul versus 200 mul   pcr although   roche amplified product can   used directly subsequent genotyping using   line probe method inno lipa hcv ii innogenetics inc     tma product   possible only after an additional amplification     other hand   tma assay   very easy   perform does   require repeated vortexing   does   roche assay   requires minimal instrument maintenance   time   results   hands  time per sample were measured once   each individual assay setup  both   substantially better   tma analysis even when   large number   specimens   tested consequently labor costs   lower     tma assay   general cost   disposables   also lower   tma assay   these costs remain well below 2 per reportable result   both assays comparing list prices   both assays   reagent cost   roche pcr analysis   significantly lower than       tma assay although manufacturers volume discounts certainly influence final pricing fig 1  detailed   global representation   hands    handsoff h  time   hcv diagnosis     roche pcr amplicor version 2 detailed   global representation   hands    handsoff h  time   hcv diagnosis     roche pcr amplicor version 20 assay     bayer tma assay break indicates   technologists time away     bench neither assay was delayed   these breaks   bars reflect respective amounts   hands    handsoff time   both assays   well   their relative positions within   assay timelines ttu test tube unit   fixed row   10 test tubes used     tma assay   summary tma analysis compares well   pcr amplification   ease   use   reliability   results only   roche pcr test   fda cleared     time because larger numbers   samples can   processed     shorter time than     pcr assay   tma assay may     assay   choice     laboratory   requires short turnaround times   can accept   larger required sample volume   tma assay may   especially useful   laboratories   large numbers   qualitative hcv diagnostic requests
12202596.txt 4 
